org placeholder image

Emily Dinatale

Senior Research Associate at Edgewise Therapeutics

  • LinkedIn

Email Email: e****@edgewisetx.com

phone noPhone Number: (***)-***-****

map
EDGEWISE THERAPEUTICS

EDGEWISE THERAPEUTICS

  • description Description
    Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions....

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Edgewise Therapeutics Org Chart and Mapping

Employees

Mina Usui

Research Outsourcing

Mike Figge

Executive Director, Legal Affairs

Badreddin Edris

Co-Founder & Board Member

Ericka Benson

Vice President Program Management

Maureen Franco

VP Corporate Communications

Emily Dinatale

Senior Research Associate

Stephen Schlachter

Senior Scientist - Chemistry

Frequently Asked Questions Regarding Emily Dinatale

Answer: Emily Dinatale works for Edgewise Therapeutics as Senior Research Associate

Answer: Emily Dinatale’s role in Edgewise Therapeutics is Senior Research Associate

Answer: Emily Dinatale's email address is e***@gmail.com

Answer: Emily Dinatale's business email address is e****@edgewisetx.com

Answer: Emily Dinatale’s direct phone number is (***)-***-****

Answer: Emily Dinatale works in the industry of: Biotechnology

Answer: Emily Dinatale works Edgewise Therapeutics located at 1715 38th St, Boulder, Colorado, 80301, United States

Answer: Edgewise Therapeutics's Senior Research Associate is Emily Dinatale

Answer: Emily Dinatale contact details:

  • Phone number  :  (***)-***-****
  • Email  :  e****@edgewisetx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access